Fluoroquinolones (FQ) Project

Clostridium difficile infection (CDI) is a critical public health issue for which new prevention strategies are urgently needed. The proposed study will evaluate the effectiveness and implementation of a fluoroquinolone preprescription authorization as an antibiotic stewardship strategy to target and prevent CDI, promote appropriate antibiotic use, and reduce the transmission of resistant bacteria. This work will contribute to the long-term goal of reducing the burden of CDI, which is an essential step in improving the safety and quality of healthcare.

Nasia Safdar, MD, PhD
Professor
School of Medicine and Public Health
University of Wisconsin – Madison

Roger Brown, PhD
Professor
Clinical Health Science
University of Wisconsin – Madison

Nicole Brys, MPH
Researcher
School of Medicine and Public Health
University of Wisconsin – Madison

Pascale Carayon, PhD
Procter & Gamble Bascom Professor in Total Quality
Department of Industrial and Systems Engineering
Director, Center for Quality and Productivity Improvement
University of Wisconsin-Madison

Aurora Pop-Vicas, MD, MPH
Assistant Professor
School of Medicine and Public Health
University of Wisconsin – Madison

Lucas Schulz, PharmD, BCPS
Clinical Pharmacist
University of Wisconsin Hospital and Clinics

Publications forthcoming…

Tools forthcoming…